✦ LIBER ✦

PCV22 COST-EFFECTIVENESS ANALYSIS OF RIVAROXABAN IN PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL HIP REPLACEMENT IN SLOVAKIA

✍ Scribed by Lukac, M; Bielik, J; Lees, M; Foltan, V; Tomek, D

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV86 COST-UTILITY ANALYSIS OF RIVAROXAB

✍ R Pereira; A Diamantopoulos; J Bielik; M Lees; D Tomek; M Lukac 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

PCV43 COST-EFFECTIVENESS ANALYSIS OF RIV

✍ P. Vorobyev; L. Krasnova; O. Borisenko; D. Lukyantseva; E. Bashlakova 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PCV42 Model Sensitivity Analysis of Veno

✍ P. Vorobiev; L. Krasnova; A. Shustov; E. Bashlakova 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PCV49 COST-EFFECTIVENESS ANALYSIS OF RIV

✍ P. Vorobyev; L. Krasnova; O. Borisenko; D. Lukyantseva; E. Bashlakova 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

PCV42 Cost Analysis of Venous Thromboemb

✍ B. Marmarali; F. Altintas; K. Bal; K. Bozkurt; M. Demir; B. Erdemli; B. Ince; G. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PCV19 COST-EFFECTIVENESS OF RIVAROXABAN

✍ Chen, XB; Eggington, S; Wang, CY; Zhu, M 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB